Lisa M. DeFrancesco | Vice President Investor Relations |
Mark E. Pruzanski | President, Chief Executive Officer & Director |
Jerome B. Durso | Chief Operating Officer |
Sandip S. Kapadia | Chief Financial Officer & Treasurer |
Alethia Young | Cantor Fitzgerald Securities |
Michael J. Yee | Jefferies LLC |
Yasmeen Rahimi | ROTH Capital Partners LLC |
Brian Abrahams | RBC Capital Markets LLC |
Dushyanth Srinivasan | Cowen and Company, LLC |
Navin Jacob | UBS Securities LLC |
Ross Weinreb | Goldman Sachs & Co. LLC |
Geoffrey Meacham | Bank of America Merrill Lynch |
Brian Peter Skorney | Robert W. Baird & Co., Inc. |
Steven Seedhouse | Raymond James & Associates, Inc. |
Liisa Bayko | JMP Securities LLC |
Michael Morabito | Chardan Capital Markets, LLC |
Mayank Mamtani | B. Riley FBR, Inc. |
Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Intercept Pharmaceuticals Earnings Conference Call. At this time all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]
I would now like to turn this conference call to Ms.